SCOPUS 정보 검색 플랫폼

Clinical Pharmacology and Therapeutics

Volumn 80, Issue 5, 2006, Pages 549-551

Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of piroxicam

(2) Perini, Jamila A a Suarez Kurtz, Guilherme a

a INSTITUTO NACIONAL DE CÂNCER (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYTOCHROME P450 2C9; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TENOXICAM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYP2C9 PROTEIN, HUMAN; PROSTAGLANDIN SYNTHASE INHIBITOR; UNSPECIFIC MONOOXYGENASE;

AREA UNDER THE CURVE; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; BLOOD; GENETICS; HALF LIFE TIME; METABOLIC CLEARANCE RATE; METABOLISM; TIME;

AREA UNDER CURVE; ARYL HYDROCARBON HYDROXYLASES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GENOTYPE; HALF-LIFE; HUMANS; METABOLIC CLEARANCE RATE; PIROXICAM; TIME FACTORS;

EID: 33750942326 PISSN: 00099236 EISSN: None Source Type: Journal
DOI: 10.1016/j.clpt.2006.08.003 Document Type: Letter

Times cited : (10)

References (6)

1
- 3042654972
- CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians
- Vianna-Jorge R., Perini J.A., Rondinelli E., and Suarez-Kurtz G. CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians. Clin Pharmacol Ther 76 (2004) 18-26
- (2004) Clin Pharmacol Ther , vol.76 , pp. 18-26
- Vianna-Jorge, R.¹ Perini, J.A.² Rondinelli, E.³ Suarez-Kurtz, G.⁴

2
- 25844475933
- Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam
- Perini J.A., Vianna-Jorge R., Brogliato A.R., and Suarez-Kurtz G. Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam. Clin Pharmacol Ther 78 (2005) 18-26
- (2005) Clin Pharmacol Ther , vol.78 , pp. 18-26
- Perini, J.A.¹ Vianna-Jorge, R.² Brogliato, A.R.³ Suarez-Kurtz, G.⁴

3
- 0036336114
- Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2
- Kirchheiner J., Meineke I., Freytag G., Meisel C., Roots I., and Brockmöller J. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. Clin Pharmacol Ther 72 (2002) 62-75
- (2002) Clin Pharmacol Ther , vol.72 , pp. 62-75
- Kirchheiner, J.¹ Meineke, I.² Freytag, G.³ Meisel, C.⁴ Roots, I.⁵ Brockmöller, J.⁶

4
- 10744225344
- Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use
- Martinez C., Blanco G., Ladero J.M., Garcia-Martin E., Taxonera C., Gamito F.G., et al. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use. Br J Pharmacol 141 (2004) 205-208
- (2004) Br J Pharmacol , vol.141 , pp. 205-208
- Martinez, C.¹ Blanco, G.² Ladero, J.M.³ Garcia-Martin, E.⁴ Taxonera, C.⁵ Gamito, F.G.⁶

5
- 23944436934
- Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer
- Chan A.T., Giovannucci E.L., Meyerhardt J.A., Schernhammer E.S., Curhan G.C., and Fuchs C.S. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294 (2005) 914-923
- (2005) JAMA , vol.294 , pp. 914-923
- Chan, A.T.¹ Giovannucci, E.L.² Meyerhardt, J.A.³ Schernhammer, E.S.⁴ Curhan, G.C.⁵ Fuchs, C.S.⁶

6
- 33644837942
- Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
- Ulrich C.M., Bigler J., and Potter J.D. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6 (2006) 130-140
- (2006) Nat Rev Cancer , vol.6 , pp. 130-140
- Ulrich, C.M.¹ Bigler, J.² Potter, J.D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.